Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study

Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims

(2023) Koshiro Kanaoka et al.   CIRCULATION JOURNAL

Validity of diagnoses of respiratory diseases recorded in a Japanese administrative database

(2023) Nobuyasu Awano et al.   Respiratory Investigation

Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: The LIFE-VENUS Study

(2022) Wataru Mimura et al.   VACCINE

Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study

(2022) Chieko Ishiguro et al.   VACCINE

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study

(2022) Wataru Mimura et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data

(2021) Gabriel Chodick et al.   CLINICAL INFECTIOUS DISEASES

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

(2021) Eleftheria Vasileiou et al.   LANCET

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

(2021) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study

(2021) Cynthia Luise et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada

(2021) Danuta M Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar

(2021) Roberto Bertollini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

(2021) Hiam Chemaitelly et al.   NATURE MEDICINE

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

(2021) Jamie Lopez Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province

(2021) Maria Elena Flacco et al.   Vaccines

Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England

(2021) Thomas F. D. Mason et al.   BMC Medicine

High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern Sweden

(2021) Jonas Björk et al.   Infectious Diseases

Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans

(2021) Yinong Young-Xu et al.   JAMA Network Open

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database

(2020) Daisuke Shima et al.   Journal of Clinical Hypertension

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE